IMARC Group has recently released a new research study titled “United States Biobanking Market Report by Specimen Type (Blood Products, Solid Tissue, Cell Lines, Nucleic Acid, and Others), Biobank Type (Population-based Biobanks, Disease-oriented Biobanks), Application (Therapeutics, Research), End User (Academic Institutions, Pharma and Biotech Companies), and Region 2025-2033”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.
United States Biobanking Market Overview
United States biobanking market reached USD 15.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 34.0 Billion by 2033, exhibiting a growth rate (CAGR) of 7.91% during 2025-2033.
Market Size and Growth
Base Year: 2024
Forecast Years: 2025-2033
Historical Years: 2019-2024
Market Size in 2024: USD 15.9 Billion
Market Forecast in 2033: USD 34.0 Billion
Market Growth Rate (2025-2033): 7.91%
Key Market Highlights:
✔️ Expanding focus on personalized medicine driving biobanking initiatives.
✔️ Growing investments in research and development for disease prevention and treatment.
✔️ Enhanced regulatory support and collaboration among institutions promoting biobanking efforts.
Request for a sample copy of the report: https://www.imarcgroup.com/united-states-biobanking-market/requestsample
United States Biobanking Market Trends
Expansion of Personalized Medicine
A significant trend shaping the United States Biobanking Market is the growing emphasis on personalized medicine. As healthcare shifts towards more individualized treatment plans, biobanks are becoming essential for storing biological samples that can be used to tailor therapies to specific patient needs. This movement is expected to drive the demand for biobanking services, as researchers increasingly rely on these resources to discover biomarkers and develop targeted treatments. By 2025, the integration of biobanking with genomic research will likely enhance the capabilities of personalized medicine, further expanding the market's potential.
Increased Investment in Research and Development
Another key trend is the increase in investment in research and development within the biobanking sector. As the importance of biobanks in facilitating groundbreaking research becomes more recognized, funding from both public and private sectors is expected to rise significantly. This influx of capital will support the expansion of existing biobanks and the establishment of new facilities, ultimately enhancing the United States Biobanking Market size. By 2025, this trend will likely result in improved technologies for sample collection, preservation, and analysis, making biobanks more efficient and accessible for researchers.
Growing Demand for Biological Samples
The United States Biobanking Market share is also witnessing growth due to the increasing demand for biological samples for various applications, including drug development, disease research, and clinical trials. As pharmaceutical companies and academic institutions seek to expedite their research processes, the need for high-quality biospecimens is becoming more pronounced. By 2025, this demand will likely lead to a more competitive landscape among biobanks, prompting them to enhance their offerings and services to attract researchers and institutions looking for reliable sources of biological materials.
Focus on Ethical Practices and Regulations
Lastly, there is a heightened focus on ethical practices and regulatory compliance within the United States Biobanking Market growth. As the industry expands, concerns regarding consent, privacy, and the ethical use of biological samples are becoming increasingly important. Biobanks are implementing stricter protocols and transparency measures to ensure they meet regulatory standards and maintain public trust. By 2025, these efforts will likely contribute to a more robust and ethically sound biobanking environment, encouraging participation from donors and fostering collaboration between biobanks and research institutions.
Speak to An Analyst: https://www.imarcgroup.com/request?type=report&id=20668&flag=C
United States Biobanking Market Segmentation:
The market report segments the market based on product type, distribution channel, and region:
Specimen Type Insights:
- Blood Products
- Solid Tissue
- Cell Lines
- Nucleic Acid
- Others
Biobank Type Insights:
- Population-based Biobanks
- Disease-oriented Biobanks
Application Insights:
- Therapeutics
- Research
End User Insights:
- Academic Institutions
- Pharma and Biotech Companies
Regional Insights:
- Northeast
- Midwest
- South
- West
Competitive Landscape:
The market research report offers an in-depth analysis of the competitive landscape, covering market structure, key player positioning, top winning strategies, a competitive dashboard, and a company evaluation quadrant. Additionally, detailed profiles of all major companies are included.
Key Highlights of the Report
- Market Performance (2019-2024)
- Market Outlook (2025-2033)
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Strategic Recommendations
- Historical, Current and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Structure of the Market
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
